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Summary 
Proteolysis mediated by the interleukin 1[3-converting enzyme (ICE) homologues is an impor- 
tant mechanism of  the apoptotic process. The ICE homologue apopain/CPP-32/Yama (subse- 
quently referred to as apopain) cleaves poly(ADP-ribose)polymerase (PAR.P) early during apop- 
tosis.  Additional apoptosis-specific protein cleavages have been observed in which the direct 
involvement of ICE-like proteases has been postulated. These substrates  include the 70-kD pro- 
tein component of  the Ul-ribonucleoprotein (U1-70kD), and the catalytic subunit of  the DNA- 
dependent protein kinase  (DNA-PKcs).  The present studies  demonstrate that U1-70kD  and 
DNA-PK~ are excellent substrates for apopain, with cleavage occurring at sites that are highly 
similar to the cleavage site within PAR.P. The fragments generated from isolated protein sub- 
strates by apopain are identical to those observed in intact apoptotic cells, in apoptotic cell ex- 
tracts, and in normal cell extracts to which apopain has been added. Like PARP,  cleavage of 
these  substrates  in  apoptotic  cell extracts is  abolished by nanomolar  concentrations  of Ac- 
DEVD-CHO and micromolar amounts of Ac-YVAD-CHO,  confirming the involvement of 
apopain or an apopain-like activity. We propose that a central function of apopain or similar 
homologues in apoptosis is the cleavage of nuclear repair proteins, thereby abolishing their crit- 
ical homeostatic functions. 
F 
Proteolytic cleavage  of key  substrates  is  an  important 
biochemical mechanism underlying the apoptotic process, 
and the centrality of IL-l[3~onverting enzyme (ICE)l-like 
proteases as mediators ofapoptosis has been emphasized (1-3). 
In previous studies, we have shown that a subset of infre- 
quently  targeted  autoantigens  is  united  by  their  specific 
proteolytic cleavage early during apoptosis  (4,  5).  The ki- 
netics and inhibition characteristics of these cleavages sug- 
gested the involvement of an ICE-like protease(s), but the 
specific substrate  cutting sites  and actual  enzymatic activ- 
ity(ies)  responsible are unknown (5). 
IAbbreviations used in  this paper: Ac-YVAD-CHO, N-(N-Ac-Tyr-Val- 
Ala)-3-amino-4-oxobutanoic acid; Ac-DEVD-CHO, N-(N-Ac-Asp- 
Glu-Val)-3 amino-4-oxobutanoic  acid; DNA-PK~5, catalytic subunit of 
the DNA-dependent protein kinase; ICE, IL-11~converting enzyme; 
KRB, Krebs Ringers buffer; PARP, poly (ADP-ribose) polymerase;  SR, 
serine rich; U1-70kD, 70kD protein component  of the U1 small nuclear 
ribonucleoprotein. 
Apopain (CPP32) is an ICE homologue (6) that has re- 
cently been shown to cleave poly(ADP-ribose) polymerase 
(PARP) during apoptosis (7, 8). Specific inhibition of apo- 
pain (or apopain-like) activity attenuates apoptosis in vitro, 
strongly suggesting that proteolytic activity of this enzyme 
is  mechanistically important in  the  apoptotic process  (8). 
Apopain is highly selective for its macromolecular and pep- 
tide substrates  (8), suggesting that if it is responsible for the 
cleavage  of other  substrates  during  apoptosis,  these  sub- 
strates  would share similar cleavage sites.  We demonstrate 
here that apopain cleaves the catalytic subunit of the DNA- 
dependent protein kinase (DNA-PKcs), the 70-kD protein 
component of the Ul-ribonucleoprotein (U1-70kD), and 
PARP with comparable catalytic efficiencies. Furthermore, 
apopain cleaves all three substrates at very similar sites, de- 
fining a DXXD motif as the key determinant for cleavage 
specificity by apopain. Since U1-70kD (9, 10), PARP (11), 
and DNA-PKcs (12-14) function in the splicing ofmRNA 
and the  repair of double-strand DNA breaks,  we  suggest 
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these essential homeostatic pathways during apoptosis. 
Materials  and Methods 
Cell Culture and Induction of Apoptosi:.  HeLa cells were pa.ssaged 
in  10%  heat-inactivated calf serum using standard tissue culture 
procedures.  Apoptosis was  induced by irradiation with  UVB as 
previously described (15). 
In  Vitro Cleavage of Purified  DNA-PK,  and  f~SS]Methionine- 
labeled UI-7OkD attd PARP.  cDNAs for U1-70kl) (16) and PA1KP 
(17)  were  used to drive the synthesis of [3SS]methionine-labeled 
proteins by coupled transcription/translation, and cleavage reac- 
tions were performed in the presence or absence of 42 pM apo- 
pain, as described previously for PARP  (8).  After incubation at 
37~  for the indicated times, reactions were terminated, samples 
were electrophoresed on 12% SDS-polyacrylamide gels, and intact 
proteins and fragnlents were visualized by fluorography. In vitro 
cleavage of purified DNA-PK,~ was performed similarly using 30 nM 
DNA-PK  (Promega,  Madison,  WI),  42  pM  apopain,  2  mM 
MgCI2, and 10 ~tg/ml sheared herring sperm DNA (Promega) in 
the  presence  or  absence  of 150  heM  ATP.  Addition of DNA, 
Mg  a+,  and  ATP  to  cleavage  reactions  containing apopain  and 
PAlkP or U1-70kD had no effect on cleavage (data  not shown), 
confirming that the cofactors acted on DNA-PKr  rather than on 
the  protease.  Samples were  electrophoresed  on  10%  SDS-poly- 
acrylamide  gels  containing 0.087%  bisacrylamide,  lmmunoblots 
were performed with serum AG (5) to detect the intact DNA-PK,~ 
and the  160-kD  fragment,  identical results were  obtained with 
mAb 18-2 (18),  which recognizes the intact protein and the 250- 
kD  fragment.  All reactions were  tamed out using subsaturating 
levels of substrate (< K  J,  where the appearance of product is as- 
sumed to be a first-order process. The densities of substrate and 
product bands on autoradiograms were determined on a PDI Dis- 
covery densitometry system (Protein Databases, lnc., Huntington 
Station,  NY)  with  Quantity One  software  (Protein  Databases, 
Inc.). Time courses were fit to the first-order rate equation per- 
cent of substrate cleavage =  100-(1-e  !~.,~,.IEl,x,~l  .....  ), to obtain a 
value for the catalytic constant k,,/K,,. 
In  Vitro Cleavqe.e of Endogenous UI-7OkD,  PARP,  and DNA- 
PK,.  Control or early apoptotic HeLa cells (incubated for 3 h atier 
UVB  irradiation) were  washed  in Krebs Ringers buffer (KRB), 
and then harvested by scraping into KRB, followed by centrifu- 
gation at 400 g.  The cell pellet was lysed on ice in 1 nil of lysis 
buffer containing 10 mM Hepes/KOH, pH 7.4, 2 mM EDTA, 
5 mM DTT, 1% NP-40, and the protease inhibitors PMSF, anti- 
pain,  leupeptin, and pepstatin A.  Protein concentrations of cell 
lysates  were  3-4 mg/ml,  and were  obtained from  six  confluent 
10-cm dishes of HeLa cells. To investigate the in vitro cleavage of 
endogenous U1-70kD, PARP, and DNA-PK,, 25-~tl aliquots of 
control  or  apoptotic  cell  lysate  were  incubated at  37~  in  the 
presence (control lysate)  or absence (apoptotic lysate)  of 105  pM 
added apopain. Samples were electrophoresed on 10% SDS-poly- 
acrylamide gels containing 0.087% bisacrylamide. Cleavage of the 
intact proteins was assayed by immunoblotting  with monospecific 
human  sera  recognizing  U1-70kD  and  PARP  (5),  or  a  n~.b 
raised against DNA-PK,~ that detects the intact I)NA-PK, and a 
250-kD fragment in apoptotic cells (18). 
KinaseAssay.  Reaction  mixtures  (30-p.1  final volume) con- 
tained  10 mM Hepes,  pH  7.4, 2  mM  MgCl:,  10 mM KC1,  2.7 
mM DTT, 150 ~M ATP, 10 la.g/rnl DNA, 50 ng DNA-PK, and 
100 ng SPI (Promega) in the absence or presence of 0.75 U/p.1 of 
apopain,  100  nM  Ac-DEV1)-CHO,  or  100  nM  Ac-YVAD- 
CHO.  All reactions were preincubated on ice for  15 rain in the 
absence  of ATP  (to  facilitate  binding of the  inhibitors, where 
added,  to apopain), and then at 370(  ". for  10 rain (to allow apo- 
pain-mediated cleavage ofDNA-PK~,). Kinase reactions were then 
initiated by adding 150  btM ATP containing 1.5  liCi  [32p]ATP 
(3,(100 Ci/mmol) to each sample. After incubating at 37~  for 10 
rain, reactions were ended by adding SDS get buffer and boiling. 
Samples were analyzed by electrophoresis on 8% SDS-polyacryl- 
anaide gels, followed by autoradiography. Phosphorylation of Spl 
was in the linear range of detection for the first 20 rain of the as- 
say,  while autophosphorylation was maximal within 5 rain (data 
not shown).  Autophosphorylated DNA-PK, provided a conve- 
nient internal control for the status (intact vs. cleaved) of the ki- 
nase.  (;leaved status of the  kinase was  also  confinned indepen- 
dently by immunoblotting experiments (data not shown). 
Determination of the Cleavage Site within U I- 7OkD.  The  full-length 
cDNA  clone  for  U1-70kl),  ligated  into  the  EcolLl  site  of 
pGEM-3Zf(+),  was used to generate [3sS]U1-70kD by coupled 
in vitro transcription/translation (T7 polymerase, rabbit reticulo- 
cyte  lysate;  Promega)  in the  presence  of either  [3SS]cysteine or 
[3SS]methionine.  The radiolabeled [3ss]uI-70kD polypeptides were 
purified by Superdex-75/FPLC (Pharmacia Fine Chemicals, Pis- 
caraway, NJ) gel-pernleation chromatography. Carboxy-tenrfinal 
fragments of the U1-70kD polypeptide, corresponding to poten- 
tial apopain cleavage sites (EAGD324A  32s and DGPD341G342), were 
generated by PCR-directed template modification followed by in 
vitro transcription/translation. A eDNA encoding the MetPro  32"- 
Glu  437 fragment (which corresponds to cleavage at EAGD324AUS) 
was amplified with the sense (forward)  synthetic oligonucleotide 
5'-GGA ATT CAT GCC CCC  TGA TGA TGG GCC TCC 
AGG G-3' plus the antisense (reverse)  oligonucleotide 5'-GGA 
ATT CTC TTC ACT CCG GCG CAG CCT CCA TC-3' us- 
ing the full-length U1-70kI) cDNA (3 ng/txl) as template (0.025 
U/I.tl Pwo polymerase [Boehringer Mannheim Biochemicals, In- 
dianapolis, IN], 25 cycles of I rain at 94~  1 rain at 60~  45 s at 
72~  A cDNA encoding the MetPro343-Glu  ~37 fragment (which 
corresponds to cleavage at l)GPI)341G  342) was amplified the same 
way, except that the sense (forward) oligonucleotide was 5'-GGA 
ATT (.'AT GCC AGA GGA AAA GGG CCG GGA TCG TG-3' 
The  resulting  PCFZ  fragments  were  pvnfied,  trimmed  with 
EcolKl, then ligated into the  EcoRl site of pBluescript II SK(+) 
(Stratagene,  La Jolla,  CA).  After sequence verification, T7-ori- 
ented clones were used to drive the synthesis of the correspond- 
ing [35S]U1-70kD COOH-terminal fragments by coupled in vitro 
transcription/translation, as described above. 
Protease Inhibitor Experiments.  Increasing concentrations of the 
tetrapeptide aldehyde inhibitor Ac-DEVD-CHO (8) were prein- 
cubated/br 20 rain on ice with apopain and/or HeLa cell lysates 
before allowing cleavage reactions to proceed at 37~  Apopain- 
mediated cleavages of purified components were  performed,  vi- 
sualized, and quantitated as described above. Cleavage of endoge- 
nous substrates  was a.~sayed in aliquots of HeLa cell lysate incubated 
in the  presence  (control lysate)  or absence  (apoptotic  lysate)  of 
105 pM  purified apopain. Maximum cleavage of the intact sub- 
strates,  measured in the absence of Ac-DEVD-CHO,  never ex- 
ceeded 50%. 
Results 
Purified Apopain  Cleaves UI-7OkD and I)NA-PK,.,  To  di- 
rectly address whether apopain cleaves UI-70kD,  a cDNA 
for  UI-70kD  was  used  to  direct  in  vitro  transcription/ 
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Figure 1.  Apopain cleaves purified U1-70kD,  DNA-PK~, and PARP in vitro, and de- 
creases DNA-PK~s  kinase activity. (A and B). Time course and kinetics of apopain-medi- 
ated substrate cleavage. Reactions containing 42 pM apopain and [35S]methionine-labeled 
U1-70kD  (squares),  [35S]methionine-labeled  PARP  (triangles),  or DNA-PKcs (circles) were 
incubated at 37~  for the indicated times. To optimize processing to the  120-kD frag- 
ment, 420 pM apopain was used for cleavage of DNA-PK~  s in the absence of cofactors. 
Samples were electrophoresed, and the intact proteins and fragments were visualized by 
autoradiography or immunoblotting.  The  kinetics of cleavage of these substrates was 
quantitated as described in Materials and Methods. (C) DNA-PK kinase assay.  Kinase as- 
says were performed in the presence of apopain (lane 2), apopain and Ac-YVAD-CHO 
(lane 3), apopaiu and Ac-DEVD-CHO (lane 4), or without additions (lane I). Phosphory- 
lation of Sp  l and autophosphorylation of DNA-PKcs  was detected by autoradiography (up- 
per panel); the scanned data are presented in the lower panel. Experiments were performed 
on five (A and B) or three (C) separate occasions  with similar results. 
translation in reticulocyte lysates, and the resulting [35S]me- 
thionine-labeled protein was incubated with apopain (0.04 
U/~I; 42 pM). Two fragments of 40-kD and 22-kD were 
simultaneously generated (Fig.  1 A) with cleavage kinetics 
(kcat/K m  =  2.3  ￿  106 M  -l"s  -1) very similar to those for the 
apopain-mediated  cleavage  of  [35S]methionine-labeled 
PARP  (kcat/Krn  ~  5.0  ￿  106 M-l-s  -1) (Fig. 1, A  and B). In 
the presence ofDNA,  Mg  2+ and ATP, purified DNA-PKc, 
was also efficiently cleaved by 42 pM apopain; the kcat/K  m 
of 7.7  ￿  106  M-I"s -1 was comparable to that for apopain- 
mediated cleavage of PAR.P (Fig.  1, A  and B). Two major 
fragments of 160-  and 250-kD  (each immunoblotted by a 
different antibody)  were  generated  (see  Figs.  1  A  and  3); 
these comigrated with the fragments formed during apop- 
tosis in intact cells (see reference 5  and Fig. 3).  In the ab- 
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sence  of Mg  2+  or ATP,  the  160-kD  fragment was further 
processed to 120 kD (Fig. 1 A, middle  panel) ; the latter frag- 
ment, however, was never observed in lysates of intact ap- 
optotic cells (5). When DNA was also omitted from the re- 
action,  cleavage of DNA-PKcs was  '~10-fold less efficient 
(data not  shown).  The  increased efficiency of cleavage of 
DNA-PK  in the presence of DNA  fragments in vitro sug- 
gests that the active DNA-PK holoenzyme, bound at DNA 
ends and nicks (19-21),  is the physiologic target for cleav- 
age by apopain. 
To  address the  effects of cleavage on  DNA-PI4xs func- 
tion,  kinase  activity was  measured  by quantitating DNA- 
dependent phosphorylation of the transcription factor Spl 
(22). When the DNA-PK  holoenzyme was incubated with 
Spl  in  the presence of cofactors and  [~/32p]ATP, both the substrate and DNA-PKcs itself were phosphorylated (Fig.  1 
C,  upper panel).  Cleavage  of DNA-PK~s  by apopain pro- 
duced a  50% decrease in  Spl  phosphorylation (Fig.  1  C, 
lanes  I and 2).  Incubation with 100 nM Ac-DEVD-CHO 
(K~ apopain =  0.35 nM) abolished apopain-mediated cleav- 
age of DNA-PKcs and prevented the decrease in kinase ac- 
tivity (Fig.  1 C, lane 4 vs. lane  1). In contrast, cleavage of 
DNA-PKcs still  occurred in  the presence of 100  nM Ac- 
YVAD-CHO (/~ apopain =  10 ~M) and was associated with 
a 50% decrease in kinase activity (Fig.  1 C, lanes 2 and 3). 
Apopain-mediated  Cleavages of U1-7OkD  and  DNA-PK~s 
Occur at  DGPD341-G 342  and  DEVD2712-N 2713, Respectively. 
The  excellent cleavage  of PARP,  U1-70kD,  and  DNA- 
PKcs by apopain, as well as the restricted substrate specific- 
ity of apopain, suggested that these three substrates  share a 
common or similar DEVD-like cleavage site.  To elucidate 
the cleavage site of U1-70kD, we labeled an in vitro trans- 
lation reaction with  [3SS]cysteine, since only a single cys- 
teine exists in U1-70kD (at position 39). When this protein 
was  cleaved with  apopain,  only the  40-kD  fragment was 
detected,  in  contrast  to  the  detection  of both  fragments 
when labeling with [3SS]methionine (Fig.  2 A, lanes  1-8). 
This suggested that the cleavage site resided in the COOH- 
terminal third of the molecule, where, given the absolute 
requirement for Asp  in  the  P1  position for this  family of 
proteases, there are two potential sites that could give rise to 
appropriately sized fragments (after Asp 324 or Asp34t). NH2- 
terminal radiosequencing of the 3H-leucine-labeled 22-kD 
fragment failed to detect radioactivity in the first 20 cycles 
of Edman  degradation,  suggesting  that  apopain-mediated 
cleavage occurred at the Asp  TM site (since the Asp  324 cleav- 
age would generate a fragment with leucine in position 11). 
Owing  to  a  lack  of suitable  radiosequencing amino  acids 
downstream of this site,  appropriate truncations of the U1- 
70kD cDNA were generated, which encoded the COOH- 
terminal portions of  U1-70kD predicted to arise from cleav- 
age  between  Asp324-Ala  32s  or  Asp341-Gly  342.  These  PCR 
products were then used for in vitro transcription/transla- 
tion with [35S]methionine  to generate the corresponding 35S 
polypeptides  (MetPro326-Glu 437  and  MetPro343-Glu 437,  re- 
spectively). The truncated products were electrophoresed 
adjacent to the full-length UI:70kD  cleaved in vitro with 
apopain.  The smaller product  (corresponding to  cleavage 
after Asp  TM)  comigrated with the  22-kD fragment gener- 
ated  by  apopain,  placing  the  cleavage  at  DGPD341-G342 
(Fig.  2 A, lanes  9-11).  To determine the cleavage site of 
DNA-PKcs, purified kinase was  cleaved in vitro with apo- 
pain, and the NH2-terminal sequence of the 160-kD frag- 
ment was determined by conventional Edman microsequenc- 
ing. The sequence obtained placed the apopain cleavage site 
in DNA-PKcs at DEVD2712-N2713 (Fig. 2 B). 
In  Vitro Cleavage Fragments Are Identical to  Those Detected 
in Intact Apoptotic Cells.  To directly compare the fragments 
generated by apopain  activity on purified substrates  with 
those observed in  apoptotic cells  or generated by incuba- 
tion  of apoptotic  cell extracts,  we  established an in  vitro 
cell lysate system that  supported  the  activity of ICE-like 
proteases. Although little specific cleavage of endogenous 
Figure  2.  Apopain-mediated cleavage of U1-70kD occurs between 
Asp  341 and Gly  342. (A) Cleavage  of [3SS]cysteine-  vs. [3SS]methionine-labeled 
U1-70kD  (lanes  1-8)  and  identification  of  the  apopain  cleavage  site 
within U1-70kD  by comigration with U1-70kD  carboxy-terminal frag- 
ments (lanes 9-1 I). [3SS]cysteine-  (lanes 1-4) and [3SS]methionine-labeled 
U1-70kD  (lanes 5-8)  were  cleaved with the indicated amounts  of apo- 
pain  for  60  min  at  37~  Lane  9,  [3SS]methionine-labeled  MetPro  326- 
G1u437; lane  I0,  full-length [3SS]methionine-labled U1-70kD  cleaved for 
60 rain at 37~  with 0.25 U/p3 ofapopain; lane 11, [35S]methionine-labeled 
MetPro343-Glu  437. All samples were electrophoresed on SDS-polyacrylamide 
gels and visualized by fluorography.  The COOH-terminal  fragments mi- 
grate aberrantly slowly on SDS-PAGE,  consistent with previous observa- 
tions (16).  (B) Location ofapopain cleavage sites in U1-70kD, DNA-PKc~, 
and  PARP.  In  addition  to  the  proven  cleavage  site  in  DNA-PKrs 
(DEVD-N,  solid  arrowhead),  three  other  potential  sites  (after  Asp  2982, 
Asp  TM, and Asp  366~ are indicated (open arrowheads) which might give rise 
to the  120-kD  fragment seen after in vitro cleavage with apopain in the 
absence of Mg  2+ or ATP. 
U1-70kD, DNA-PKcs, or PAR.P was detected upon incu- 
bation of control (nonapoptotic) HeLa cell lysates in vitro 
(Fig.  3,  lanes  3  and  4),  significant cleavage of these  sub- 
strates  occured  when  lysates  made  from  early  apoptotic 
HeLa cells were incubated at 37~  (Fig.  3, lanes  6 and  7). 
Efficient cleavage of all endogenous substrates  could also be 
induced in control lysates by addition of 105 pM apopain 
(Fig. 3, lane 5). All fragments generated in control or apop- 
totic cell lysates  using exogenous or endogenous apopain, 
respectively, comigrated exactly with those observed in in- 
tact  apoptotic  cells  (Fig.  3,  compare  lanes  2,  5,  and  7). 
Identical findings were made using lysates of human kerati- 
nocytes or an osteosarcoma cell line (data not shown). 
Ac-DEVD-CHO Inhibits the Apopain-mediated Cleavage of 
U1-7OkD,  DNA-PKcs  , and PARP.  Previous  studies  have 
1960  Apopain-mediated Proteolysis  of  DNA-PKcs and U1-70kD during Apoptosis 0.4 nM; Fig. 4, upper  panel). In contrast, the potent ICE in- 
hibitor Ac-YVAD-CHO (24) was 10,000-fold less efficient 
at inhibiting cleavage of these substrates in all three settings; 
IC50 values ranged from 5-10 ~M (data not shown). Taken 
together, these data confirm that the activity responsible for 
cleavage of these substrates  in apoptotic cells is apopain or 
apopain-like, rather than ICE-like. 
Discussion 
These studies  define DNA-PK~  s and  U1-70kD  as  two 
novel apopain substrates.  Both are cleaved in vitro with very 
sitnilar  kinetics  to  PARP,  the  other known  substrate  for 
apopain. The cleavage fragments generated by apopain on 
purified components are identical to those observed in in- 
Figure 3.  In vitro cleavage fragments are identical to those observed in 
intact apoptotic  cells.  Lysates  of control  (lane  1)  or apoptotic  (lane  2) 
HeLa  cells  were  electrophoresed adjacent to  in  vitro  cleavage reactions 
performed on control (lanes 3-5) or early apoptotic (lanes  6 and 7) HeLa 
lysates.  Cleavage was initiated by incubating lysates  at 37~  in the pres- 
ence (lane 5) or absence (lanes 3,  4,  6, and  7) of exogenous apopain for 
the indicated times. U1-70kD, PAR.P, and DNA-PKcs were detected by 
irtLmunoblotting. 53 I~g of  protein was electrophoresed in each lane. Data 
from a representative experiment are shown; similar data were obtained in 
10 other experiments. 
demonstrated that apopain and ICE differ in their specifici- 
ties,  as  well  as  in  their  promiscuity  toward  peptide  and 
macromolecular substrates.  For example, while apopain is 
highly specific for PARP and does not cleave pro-IL-l~, 
even at 5000-fold excesses  of the enzyme (8), ICE is more 
promiscuous, showing only a 50-100 fold preference for pro- 
IL-I~ over PARP (23). Similarly, while there is a >10,000 
fold selectivity by apopain for the Ac-DEVD-AMC  over 
the Ac-YVAD-AMC fluorogenic substrate,  the relative pre- 
ference of ICE for Ac-YVAD-AMC over Ac-DEVD-AMC 
is only approximately fivefold (Thornberry, N.A., unpub- 
lished  data).  U1-70kD,  DNA-PKc,,  and  PARP  were  all 
cleaved  by purified  ICE  in  vitro,  albeit  at  ~30-50-fold 
higher enzyme concentration than is required for the pro- 
cessing of these substrates  by apopain (data not shown). To 
identify the activity responsible for the physiologic cleavage 
of these substrates  during apoptosis, we determined the tet- 
rapeptide aldehyde inhibition profile for cleavage of endog- 
enous substrates in apoptotic extracts (Fig.  4).  Ac-DEVD- 
CHO  was  a  potent  inhibitor  of cleavage  of endogenous 
U1-70kD,  DNA-PKcs,  and PARP  in  apoptotic HeLa ly- 
sates  (ICs0  =  0.2-1  nM;  Fig.  4,  lowest panel),  and of apo- 
pain-mediated cleavages in control lysates  (ICs0  =  0.2--0.5 
nM; Fig. 4, middle panel). These effects of  Ac-DEVD-CHO 
were identical to those observed for inhibition of apopain- 
mediated cleavage of the purified substrates  (ICs0  =  0.1- 
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Figure  4.  Inhibition  of apopain-mediated U1-70kD,  DNA-PK~s  ,  and 
PARP cleavages by Ac-DEVD-CHO. (Top panel) In vitro apopain-mediated 
cleavage  of [35S]methionine-labeled U1-70kD,  [35S]methionine-labeled 
PARP, or purified DNA-PI~s is inhibited by Ac-DEVD-CHO; ICs0  = 
0.1-0.4 nM. (Middle panel) Ac-DEVD-CHO inhibits the in vitro cleavage 
of endogenous substrates in control lysates  (incubated in the presence of 
added purified apopain); IC50 =  0.2-0.5 nM. (Lmve-~tpanel) Ac-DEVD-CHO 
inhibits the endogenous protease-mediated cleavages  in  early apoptotic 
lysates with ICs0 values of 0.2-1 riM. Squares,  U1-70kD; triangles, PARP; 
circles, DNA-PKc,. The experiments were repeated on two to three sepa- 
rate occasions with identical results. tact apoptotic cells or generated in lysates of apoptotic cells 
incubated  in  vitro.  The  tetrapeptide  aldehyde  inhibition 
profile of substrate  cleavage in  extracts  of apoptotic  cells 
showed ICs0 =  0.2-1 nM for Ac-DEVD-CHO, but ICs0 = 
5-10  p~M for Ac-YVAD-CHO,  confirming that  apopain 
or a very closely related activity is responsible for the phys- 
iologic cleavage of these substrates  in apoptotic cells. 
All three apopain substrates  share extremely similar cleav- 
age sites,  comprising DEVD-N  in  DNA-PKcs,  DGPD-G 
in U1-70kD, and DEVD-G in PARP. In all cases, aspartate 
is found in P1 and P4, defining a DXXD  motif as the key 
determinant for specificity of cleavage by apopain. These sites 
differ at the P4 position from those sites efficiently cleaved 
in  prolL-l[~ by ICE  (FEAD-G  and YVHD-A)  (25,  26). 
Strikingly, cleavage separates  key functional domains of the 
molecule in all three cases (Fig. 2 B): (a) the RNA-binding 
domain from the  distal  arginine-rich region of U1-70kD 
(16);  (b)  the  NH2-terminal  domains  containing a  leucine 
zipper  motif from  the  COOH-terminal  PI3  kinase-like 
domain of DNA-PKc~ (27);  and (c) the DNA-binding do- 
main from the  catalytic and automodification domains  of 
PARP (28). 
Cells are equipped with several complex strategies  to re- 
pair various types of DNA damage. These include  (a) the 
sensing of  DNA damage by a family ofPI3 kinase-like pro- 
teins (29),  and potentially by PARP  (11);  and (b) the acti- 
vation of several checkpoint proteins (e.g., p53), that arrest 
the cell cycle and thereby allow DNA repair to occur by 
base excision repair pathways (30),  nucleotide excision re- 
pair  pathways  (31),  mismatch  repair  pathways  (32),  and 
pathways for double-strand DNA break repair (27).  It is of 
great interest that DNA-PKcs and PARP are substrates  for 
apopain, and that several other proteins also possess DXXD 
sequences and might conceivably be substrates  for apopain 
during apoptosis. These include (a) uracil DNA glycosylase 
(involved in  base-excision repair and  contains  a DIED-F 
sequence at an exposed loop at positions 180-184 [33]); (b) 
the  PI3  kinase  homologue  FKBP  rapamycin-associated 
protein  (FRAP)  (implicated  in  mediating  G1  cell  cycle 
progression (34), and contains a DHTD-G sequence at res- 
idues  1538-1542  and  a  DLLD-A  sequence  at  residues 
1569-1573); and (c) the PI3 kinase homologue ATM (mu- 
tated in ataxia telangiectasia and postulated to function in 
cell cycle control, and contains a DIVD-G sequence at res- 
idues  1565-1569  of the  partial  cDNA  sequence  [35]).  It 
will  be  important  to  address  whether  these  proteins  are 
cleaved by apopain in apoptotic cells. Since the cellular ma- 
chinery necessary to sense and repair DNA damage would 
counteract the DNA degradation characteristic of apopto- 
sis, destruction of this machinery would be physiologically 
essential  if the decision to die is to be irreversible and rap- 
idly executed. 
Mutations  in  several of the  proteins involved in DNA 
repair discussed above (e.g.,  DNA-PKc~, ATM) have been 
associated with severe phenotypes and/or susceptibility to 
malignancy, suggesting that the abolition of their function 
severely impairs DNA repair processes (27, 35, 36).  In con- 
trast, the phenotype observed in PARP knockout mice was 
minimal (37),  suggesting that PARP function in DNA re- 
pair is redundant, and hence that its proteolysis in apoptosis 
does  not  exert  any functional  effect by  loss  of function 
alone. The possibility that one of the apoptotic PARP frag- 
ments has a dominant negative role in abrogating DNA re- 
pair has been suggested (38), but remains to be directly ad- 
dressed. 
Overexpression of the COOH-terminal domain of U1- 
70kD (which contains two arginine/serine-rich [SR] regions) 
has a dominant negative effect on splicing and transport of 
mRNA  to  the  cytoplasm  (39).  Interestingly,  the  22-kD 
fragment generated by apopain  contains  one of these  SR 
domains,  and would likely have a similar effect. Since re- 
pair pathways depend on new mRNA synthesis, inhibition 
of mRNA splicing during apoptosis might impair expres- 
sion of the homeostatic transcriptional response. Domains 
similar to the SR domain in U1-70kD are also found in an 
extended family of splicing factors, the SR proteins (40).  It 
is therefore of great interest that five members of this SR 
family contain  a  D  XD  sequence just  upstream  of their 
SR domains  (40).  It will be important to address  whether 
these proteins are also cleaved during apoptosis, potentially 
liberating many SR domains and thereby abolishing mRNA 
splicing.  The cleavage of nuclear lamins by an ICE-like en- 
zyme during the later phases of apoptosis has recently been 
recognized (41,  42), and might facilitate nuclear condensa- 
tion and fragmentation during the later phases  of this pro- 
cess. Since these intermediate filament proteins have a role 
in nuclear envelope integrity and the organization of inter- 
phase  chromatin  (43),  the  altered nuclear structure might 
also  limit  those functions  (e.g.,  transcription  and mRNA 
splicing)  that are topographically organized. 
The specific proteolytic cleavages and DNA breaks that 
proceed rapidly during  the  execution phase  of apoptosis 
imply that macromolecule degradation far outpaces repair 
(3).  We  propose  that  the  efficient  cleavage by  a  single, 
highly specific protease of three nuclear proteins involved 
in  homeostatic  pathways  eliminates  essential  repair  func- 
tions.  The  focused  crippling  of homeostasis  by  apopain 
(and potentially other similar homologues) may be a funda- 
mental feature ensuring the rapid irreversibility of the apop- 
totic process. 
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